INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 78 filers reported holding INSTIL BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,512 | +5.4% | 6,828 | 0.0% | 0.00% | – |
| Q4 2022 | $4,280 | -87.0% | 6,828 | 0.0% | 0.00% | – |
| Q3 2022 | $33,000 | +22.2% | 6,828 | +16.4% | 0.00% | – |
| Q2 2022 | $27,000 | -55.7% | 5,866 | +2.2% | 0.00% | – |
| Q1 2022 | $61,000 | -37.8% | 5,738 | 0.0% | 0.00% | – |
| Q4 2021 | $98,000 | +127.9% | 5,738 | +140.6% | 0.00% | – |
| Q3 2021 | $43,000 | -6.5% | 2,385 | 0.0% | 0.00% | – |
| Q2 2021 | $46,000 | +253.8% | 2,385 | +377.0% | 0.00% | – |
| Q1 2021 | $13,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
| CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
| VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
| Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
| Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
| Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
| RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
| Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
| HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
| Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |